Photo Credit: AI
The following is a summary of “Bibliometric analysis of the trends and evolution in β-lactam allergy research,” published in the November 2024 issue of Allergy and Immunology by Mak et al.
β-Lactams are the most reported drug allergy worldwide, with increasing research in this area. Identifying research trends can guide future directions and foster collaborations.
Researchers conducted a retrospective study on β-lactam allergy publications, analyzing publication rates, international collaborations, and key trends.
They analyzed meta-data from all original articles, letters, and reviews related to β-lactam allergy in the Web of Science Core Collection until December 31, 2023. The analysis included publications from various categories to identify trends and collaborations.
The results showed 4,451 records (3,536 articles, 631 reviews, 284 letters) from 78 countries between 1966 and 2023. Publications increased exponentially, with 50.6% (2,252 of 4,452) published in the last decade. International coauthorships accounted for 18.1% (805 of 4,452), rising from 12.7% to 23.3% (P < .001). Keywords in the first half included skin testing (84 of 1,919), IgE (57 of 1919), and anaphylaxis (49 of 1,919), while the latter half featured drug provocation test (121 of 3,351), antimicrobial resistance (120 of 3,351), and antimicrobial stewardship (118 of 3,351).
Investigators observed a significant increase in publications and international collaboration in β-lactam allergy research, with a shift toward antimicrobial stewardship. However, fewer collaborations with non-Western countries highlighted the need for further global cooperation to address mislabeled β-lactam allergies.
Source: jaci-global.org/article/S2772-8293(24)00124-3/fulltext
